Skip to main content
Loading

Automation adaptation for commercial cell therapy product: challenges and opportunities

04 Nov 2026
Cell Therapy Development
  • What are the biggest barriers preventing broader implementation of automation in commercial cell therapy manufacturing today?
  • Where does automation create the greatest value across the commercial cell therapy value chain?
  • What role will digitalization and AI-enabled decision making play in the next generation of commercial cell therapy manufacturing?
Industry Expert
Jay Kang, Executive Director, Head of CMC and External Manufacturing (Cell and Gene Therapy) - Legend Biotech